IPSEN BIOPHARMACEUTICALS

Serial Number 86844875
606

Registration Progress

Application Filed
Dec 10, 2015
Under Examination
Jan 31, 2017
Approved for Publication
Dec 6, 2016
Published for Opposition
Dec 6, 2016
Registered

Trademark Image

IPSEN BIOPHARMACEUTICALS

Basic Information

Serial Number
86844875
Filing Date
December 10, 2015
Published for Opposition
December 6, 2016
Abandonment Date
March 2, 2020
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 2, 2020
Classes
044

Rights Holder

Ipsen S.A.

99
Address
65, quai Georges Gorse
Boulogne Billancourt 92100
FR

Ownership History

Ipsen S.A.

Original Applicant
99
Boulogne Billancourt FR

Ipsen S.A.

Owner at Publication
99
Boulogne Billancourt FR

Legal Representation

Attorney
William S. Frommer,

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

41 events
Date Code Type Description Documents
Mar 2, 2020 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 2, 2020 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Aug 1, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 31, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 31, 2019 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jul 29, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 29, 2019 EXT5 S SOU EXTENSION 5 FILED Loading...
Jan 19, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 17, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 17, 2019 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 17, 2019 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jul 19, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 17, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 17, 2018 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 17, 2018 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jan 25, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 23, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 23, 2018 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 23, 2018 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 27, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 25, 2017 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 25, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 25, 2017 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 25, 2017 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 31, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 6, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 6, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 16, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 29, 2016 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Oct 25, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 5, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 5, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 22, 2016 ALIE A ASSIGNED TO LIE Loading...
Sep 13, 2016 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 29, 2016 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 29, 2016 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 29, 2016 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 28, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 15, 2015 MPMK E NOTICE OF PSEUDO MARK E-MAILED Loading...
Dec 14, 2015 NWAP I NEW APPLICATION ENTERED Loading...
Dec 14, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 044
Medical services; providing hygienic and beauty care services for human beings; information services, namely, providing advice and consulting in connection with the medical, pharmaceutical and cosmetic fields
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
IPSEN BIO PHARMACEUTICALS

Classification

International Classes
044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BIOPHARMACEUTICALS"